Vanguard Group Inc Cerus Corp Transaction History

Vanguard Group Inc

  • $5.57 Trillion
  • Q4 2024

A detailed history of Vanguard Group Inc transactions in Cerus Corp stock. As of the latest transaction made, Vanguard Group Inc holds 10,416,038 shares of CERS stock, worth $17.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,416,038
Previous 10,848,098 3.98%
Holding current value
$17.9 Million
Previous $18.9 Million 15.02%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$1.52 - $2.03 $656,731 - $877,081
-432,060 Reduced 3.98%
10,416,038 $16 Million
Q3 2024

Nov 13, 2024
BUY
$1.7 - $2.39 $619,792 - $871,355
364,584 Added 3.48%
10,848,098 $18.9 Million
Q2 2024

Aug 13, 2024
BUY
$1.62 - $2.04 $809,272 - $1.02 Million
499,551 Added 5.0%
10,483,514 $18.5 Million
Q1 2024

May 10, 2024
BUY
$1.66 - $2.42 $188,064 - $274,166
113,292 Added 1.15%
9,983,963 $18.9 Million
Q4 2023

Feb 14, 2024
BUY
$1.25 - $2.35 $151,783 - $285,353
121,427 Added 1.25%
9,870,671 $21.3 Million
Q3 2023

Nov 14, 2023
SELL
$1.5 - $3.07 $514,578 - $1.05 Million
-343,052 Reduced 3.4%
9,749,244 $15.8 Million
Q2 2023

Aug 14, 2023
SELL
$1.79 - $2.9 $806,548 - $1.31 Million
-450,586 Reduced 4.27%
10,092,296 $24.8 Million
Q1 2023

May 15, 2023
SELL
$2.65 - $3.81 $947,481 - $1.36 Million
-357,540 Reduced 3.28%
10,542,882 $31.3 Million
Q4 2022

Feb 10, 2023
BUY
$3.38 - $4.22 $1.51 Million - $1.89 Million
447,371 Added 4.28%
10,900,422 $39.8 Million
Q3 2022

Nov 14, 2022
BUY
$3.43 - $5.83 $4.19 Million - $7.13 Million
1,222,273 Added 13.24%
10,453,051 $37.6 Million
Q2 2022

Aug 12, 2022
BUY
$4.41 - $5.69 $830,698 - $1.07 Million
188,367 Added 2.08%
9,230,778 $48.8 Million
Q1 2022

May 13, 2022
BUY
$4.81 - $6.99 $1.06 Million - $1.53 Million
219,535 Added 2.49%
9,042,411 $49.6 Million
Q4 2021

Feb 14, 2022
SELL
$5.97 - $7.93 $34,363 - $45,645
-5,756 Reduced 0.07%
8,822,876 $60.1 Million
Q3 2021

Nov 12, 2021
SELL
$4.79 - $6.68 $25,272 - $35,243
-5,276 Reduced 0.06%
8,828,632 $53.8 Million
Q2 2021

Aug 13, 2021
BUY
$5.35 - $6.35 $47.3 Million - $56.1 Million
8,833,908 New
8,833,908 $52.2 Million

Others Institutions Holding CERS

# of Institutions
164
Shares Held
143M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $305M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email